Publications

Book Chapter

Treatment of Benign Prostatic Hyperplasia: Modern Alternative to Transurethral Resection of the Prostate edited by Bilal Chughtai, Alexis E. Te, Steven A. Kaplan, published by Springer 2015 Chapter Prostatic Artery Embolization – Roger Valdivieso O’Donova, Pierre-Alain Hueber, Naeem Bhojani, Quoc-Dien Trinh, and Kevin C. Zorn

Articles/Editorial Comments

Photoselective vaporization of the prostate with the 180-W XPS-Greenlight laser: Five-year experience of safety, efficiency, and functional outcomes. Ajib K, Mansour M, Zanaty M, Alnazari M, Hueber PA, Meskawi M, Valdivieso R, Tholomier C, Pradere B, Misrai V, Elterman D, Zorn KC. Can Urol Assoc J. 2018 March

Multicenter international experience of 532 nm-laser photo-vaporization with Greenlight XPS in men with extremely large prostates (prostate volume > 200 cc). Valdivieso R, Hueber PA, Meskawi M, Belleville E, Ajib K, Bruyere F, Te AE, Chughtai B, Elterman D, Misrai V, Zorn KC. BJU Int. 2018 Mar 23.

Functional and oncological outcomes of salvage external beam radiotherapy following robot- assisted radical prostatectomy in a Canadian cohort. Ajib K, Zanaty M, Alnazari M, Rajih E, Hueber PA, Mansour M, Valdivieso R, Negrean C, Karakiewicz PI, Taussky D, Delouya G, El- Hakim A, Zorn KC. Can Urol Assoc J. 2018 Feb;12(2):45-49.

Does surgical delay for radical prostatectomy affect biochemical recurrence? A retrospective analysis from a Canadian cohort. Zanaty M, Alnazari M, Ajib K, Lawson K, Azizi M, Rajih E, Alenizi A, Hueber PA, Tolmier C, Meskawi M, Saad F, Pompe RS, Karakiewicz PI, El-Hakim A, Zorn KC. World J Urol. 2018 Jan;36(1):1-6.

Greenlight® users should move from photoselective vaporization to endoscopic enucleation in larger prostates : Benoit Peyronnet, Vincent Misrai, Tev Aho, Henry Woo, Thomas Herrmann, Fernando Gomez-Sancha. Meskawi M, Hueber PA, Valdivieso R, Te AE, Chugthai B, Bhojani N, Zorn KC. World J Urol. 2018 Jan;36(1):147-148.

Assessment of Learning Curves for 180-W GreenLight XPS Photoselective Vaporisation of the Prostate: A Multicentre Study. Bastard C, Zorn K, Peyronnet B, Hueber PA, Pradère B, Rouprêt M, Misrai V. Eur Urol Focus. 2017 Sep 23.

Efficacy, Safety, and Durability of 532 nm Laser Photovaporization of the Prostate with GreenLight 180 W XPS in Men with Acute Urinary Retention. Goueli R, Meskawi M, Thomas D, Hueber PA, Tholomier C, Valdivieso R, Te A, Zorn KC, Chughtai B. J Endourol. 2017 Nov;31(11):1189-1194.

180W-LBO GreenLight XPS laser vaporization for benign prostatic hyperplasia: our experience with current markers of surgical proficiency for durable and reproducible outcomes. Zhou J, Tholomier C, Zanaty M, Hueber PA, Valdivieso R, Karakewicz P, Liberman D, Misrai V, Zorn KC. Can J Urol. 2017 Aug;24(4):8922-8931.

Does surgical delay for radical prostatectomy affect patient pathological outcome? A retrospective analysis from a Canadian cohort. Zanaty M, Alnazari M, Lawson K, Azizi M, Rajih E, Alenizi A, Hueber PA, Meskawi M, Lebacle C, Lebeau T, Benayoun S, Karakiewicz PI, El- Hakim A, Zorn KC Can Urol Assoc J. 2017 Aug

Error reporting from the da Vinci surgical system in robotic surgery: A Canadian multispecialty experience at a single academic centre. Rajih E, Tholomier C, Cormier B, Samouëlian V, Warkus T, Liberman M, Widmer H, Lattouf JB, Alenizi AM, Meskawi M, Valdivieso R, Hueber PA, Karakewicz PI, El-Hakim A, Zorn KC. Can Urol Assoc J. 2017 May;11(5):E197-E202.

Rajih E, Tholomier C, Hueber PA, Alenizi AM, Valdivieso R, Azizi M, Gonzalez RR, Eure G, Kriteman L, Hai M, Zorn KC. Evaluation of Surgical Outcomes with Photoselective GreenLight XPS Laser Vaporization of the Prostate in High Medical Risk Men with Benign Prostatic Enlargement: A Multicenter Study. J Endourol. 2017 Jul;31(7):686-693. doi: 10.1089/end.2016.0782. Epub 2017 May 16.

Meskawi M, Hueber PA, Valdivieso R, Bruyere F, Misrai V, Fournier G, Munver R, Sivarajan G, Rutman M, Te AE, Chughtai B, Elterman D, Martel T, Azizi M, Karakiewicz PI, Zorn KC. Multicenter international experience of 532 nm-laser photo-vaporization with Greenlight XPS in men with large prostates (prostate volume > 100 cc). World J Urol. 2017 Feb 22.

Azizi M, Tholomier C, Meskawi M, Hueber PA, Valdivieso R, Alenizi AM, Rajih E, Zanaty M, Hai MA, Gonzalez RR, Misrai V, Zorn KC. Safety, Perioperative and Early Functional Outcomes of Vapor-Incision Technique (VIT) using the Greenlight XPS 180-W system: Direct Comparison to Photoselective Vaporization of the Prostate (PVP) J Endourol. 2016 Nov 14.

Alenizi AM, Zorn KC, Bienz M, Rajih E, Hueber PA, Al-Hathal N, Benayoun S, Lebeau T, El- Hakim A. Erectile function recovery after robotic-assisted radical prostatectomy (RARP): long term exhaustive analysis across all preoperative potency categories. Can J Urol. 2016 Oct;23(5):8451-8456.

Hueber PA, Salgado Diaz M, Chaussy Y, Franc-Guimond J, Barrieras D, Houle AM.. Long-term functional outcomes after penoscrotal hypospadias repair: A retrospective comparative study of proximal TIP, Onlay, and Duckett. J Pediatr Urol. 2016 Aug;12(4):198

Valdivieso R, Meyer CP, Hueber PA, Meskawi M, Alenizi AM, Azizi M, Trinh QD, Misrai V, Rutman M, Te AE, Chughtai B, Barber NJ, Emara AM, Munver R, Zorn KC. Assessment of energy density usage during 180W lithium triborate laser photoselective vaporization of the prostate for benign prostatic hyperplasia. Is there an optimum amount of kilo-Joules per gram of prostate? BJU Int. 2016 Oct;118(4):633-40.

A. M. Elshal, M. A. Elkoushy, A. R. El-Nahas, A. M. Shoma, A. Nabeeh, S. Carrier, M. Elhilali, Zorn KC, Hueber PA, Gonzalez RR. GreenLight (TM) Laser (XPS) Photoselective Vapo- Enucleation versus Holmium Laser Enucleation of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia: a Randomized Controlled Study. J Urol. 2015 Nov; 194(5): 1513-4

Tholomier C, Valdivieso R, Hueber PA, Zorn KC. Photoselective laser ablation of the prostate: a review of the current 2015 tissue ablation options. Can J Urol. 2015 Oct; 22 (5 Suppl 1): 45-52.

Hueber PA, Bienz MN, Valdivieso R, Lavigueur-Blouin H, Misrai V, Rutman M, Te AE, Chughtai B, Barber NJ, Emara AM, Munver R, Trinh QD, Zorn KC. Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia Using the 180-Watt System: Multicenter Study of the Impact of Prostate Size on Safety and Outcomes. J Urol. 2015 Aug; 194(2): 462-9.

Hueber PA, Zorn KC. Let's not forget about TUIP: A highly underutilized, minimally-invasive and durable technique for men with <30 g prostates. Can Urol Assoc J. 2015 Jul-Aug; 9(7-8): 255-6.

Bienz M, Hueber PA, Trudeau V, Alenizi AM, Valdivieso R, Alom M, Balbay MD, Canda AE, Mouraviev V, Albala DM, El-Hakim A, Trinh QD, Latour M, Saad F, Zorn KC. Prevalence and risk factors of contralateral extraprostatic extension in men undergoing radical prostatectomy for unilateral disease at biopsy: A global multi-institutional experience. Can Urol Assoc J. 2015 Jul- Aug; 9(7-8)

Alenizi AM, Valdivieso R, Rajih E, Meskawi M, Toarta C, Bienz M, Azizi M, Hueber PA, Lavigueur-Blouin H, Trudeau V, Trinh QD, El-Hakim A, Zorn KC. Factors predicting prolonged operative time for individual surgical steps of robot-assisted radical prostatectomy (RARP): A single surgeon's experience. Can Urol Assoc J. 2015 Jul-Aug; 9(7-8)

Hueber PA, Antczak C, Abdo A, Franc-Guimond J, Barrieras D, Houle AM. Long-term functional outcomes of distal hypospadias repair: a single center retrospective comparative study of TIPs, Mathieu and MAGPI. J Pediatr Urol. 2015 Apr; 11(2): 68.e1-7.

Lavigueur-Blouin H, Noriega AC, Valdivieso R, Hueber PA, Bienz M, Alhathal N, Latour M, Trinh QD, El-Hakim A, Zorn KC. Predictors of early continence following robot-assisted radical prostatectomy. Can Urol Assoc J. 2015 Jan-Feb; 9(1-2): e93-7

Bienz M, Hueber PA, Al-Hathal N, McCormack M, Bhojani N, Trinh QD, Zorn KC. Accuracy of transrectal ultrasonography to evaluate pathologic prostate weight: correlation with various prostate size groups. Urology. 2014 Jul; 84(1): 169-74.

Tholomier C, Bienz M, Hueber PA, Trinh QD, Hakim AE, Alhathal N, Lebeau T, Benayoun S, Valdivieso R, Liberman D, Saad F, Lattouf JB, Widmer H, Begin L, Latour M, Zorn KC. Oncological and functional outcomes of 722 robot-assisted radical prostatectomy (RARP) cases: The largest Canadian 5-year experience. Can Urol Assoc J. 2014 May; 8(5-6): 195-201

Ben-Zvi T, Hueber PA, Valdivieso R, Azzizi M, Tholomier C, Bienz M, Bhojani N, Trinh QD, Zorn KC. Urological resident exposure to transurethral surgical options for BPH management in 2012-2013: A pan-Canadian survey. Can Urol Assoc J. 2014 Jan-Feb; 8(1-2): 54-60.

Robot assisted radical prostatectomy: how I do it. Part II: Surgical technique. Valdivieso RF,

Hueber PA, Zorn KC. Can J Urol. 2013 Dec; 20(6): 7073-8.

Hueber PA, Liberman D, Ben-Zvi T, Woo H, Hai MA, Te AE, Chughtai B, Lee R, Rutman M, Gonzalez RR, Barber N, Al-Hathal N, Al-Qaoud T, Trinh QD, Zorn KC. 180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parameters. Urology. 2013 Nov; 82(5): 1 108-13. 2013 Oct 25.

Valdivieso RF, Hueber PA, Zorn KC. Robot assisted radical prostatectomy: how I do it. Part I: Patient preparation and positioning. Can J Urol. 2013 Oct; 20(5): 6957-61.

Hueber PA, Zorn KC. Canadian trend in surgical management of benign prostatic hyperplasia and laser therapy from 2007-2008 to 2011-2012. Can Urol Assoc J. 2013 Sep-Oct; 7(9-10)

Hueber PA, Ben-Zvi T, Zorn KC, Woo H, Te AE, Lee R, Rutman M, Gonzalez RR, Barber N. Letters: Urology. 2013 Sep; 82(3): 746-7.

Ben-Zvi T, Hueber PA, Liberman D, Valdivieso R, Zorn KC GreenLight XPS 180W vs HPS 120W laser therapy for benign prostate hyperplasia: a prospective comparative analysis after 200 cases in a single-center study. Urology. 2013 Apr; 81(4): 853-8.

Hueber PA, Abdollah F, Liberman D, Bhojani N, Gautam G, Zorn KC. Short term outcomes of GreenLight vapor incision technique (VIT) of the prostate: comparison of outcomes to standard GreenLight 120W HPS vaporization in prostate volumes greater than 80 cc. Ben-Zvi T, Can J Urol. 2013 Feb; 20(1): 6633-9.

Hueber PA, Ben-Zvi T, Liberman D, Bhojani N, Gautam G, Deklaj T, Katz M, Zorn KC. Mid term outcomes of initial 250 case experience with GreenLight 120W-HPS photoselective vaporization prostatectomy for benign prostatic hyperplasia: comparison of prostate volumes < 60 cc, 60 cc-100 cc and > 100 cc. Can J Urol. 2012 Oct; 19(5): 6450-8.

O'Donova RV, Hueber PA, Zorn KC. Editorial Comment on Trends and attitudes in surgical management of benign prostatic hyperplasia. Can Urol Assoc J. 2012.

O'Donova RV, Hueber PA, Zorn KC. Editorial Comment on Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy. Urology. 2012 Sep; 80(3): 582-3

Hueber PA, Al-Asker A, Zorn KC. Monopolar vs. bipolar TURP: assessing their clinical advantages. Can Urol Assoc J. 2011 Dec. 5(6): 390-1

Zhang Z, Pascuet E, Hueber PA, Chu L, Bichet DG, Lee TC, Threadgill DW, Goodyer P. Targeted inactivation of EGF receptor inhibits renal collecting duct development and function. J Am Soc Nephrol. 2010 Apr; 21(4): 573-8

Hueber PA, Fukuzawa R, Elkares R, Chu L, Blumentkrantz M, He SJ, Anaka MR, Reeve AE, Eccles M, Jabado N, Iglesias DM, Goodyer PR. PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms tumors with myogenic phenotype. Pediatr Dev Pathol. 2009 Sep-Oct; 12(5): 347-54.

El-Kares R, Hueber PA, Blumenkrantz M, Iglesias D, Ma K, Jabado N, Bichet DG, Goodyer P. Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus. Pediatr Nephrol. 2009 Jul; 2 4(7): 1313-9.

Zhang Z, Quinlan J, Hoy W, Hughson MD, Lemire M, Hudson T, Hueber PA, Benjamin A, Roy A, Pascuet E, Goodyer M, Raju C, Houghton F, Bertram J, Goodyer P. A common RET variant is associated with reduced newborn kidney size and function. J Am Soc Nephrol. 2008 Oct; 19(10): 2027-34.

Hueber PA, Iglesias D, Chu LL, Eccles M, Goodyer P. In vivo validation of PAX2 as a target  for renal cancer therapy. Cancer Lett. 2008 Jun 28; 265(1): 148-55.

Iglesias DM, Hueber PA, Chu L, Campbell R, Patenaude AM, Dziarmaga AJ, Quinlan J, Mohamed O, Dufort D, Goodyer PR. Canonical WNT signaling during kidney development. Am J Physiol Renal Physiol. 2007 Aug; 293(2)

Dziarmaga A, Hueber PA, Iglesias D, Hache N, Jeffs A, Gendron N, Mackenzie A, Eccles M, Goodyer P. Neuronal apoptosis inhibitory protein is expressed in developing kidney and is regulated by PAX2. Am J Physiol Renal Physiol. 2006 Oct; 291(4)

Hueber PA, Waters P, Clark P, Eccles M, Goodyer P. PAX2 inactivation enhances cisplatin- induced apoptosis in renal carcinoma cells. Kidney Int. 2006 Apr; 69 (7): 1139-45.